Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C26H30N6O3 |
Molecular Weight | 474.5548 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(N)C(=O)N[C@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC3=CNC4=C3C=CC=C4)NC=O
InChI
InChIKey=UJVDJAPJQWZRFR-DHIUTWEWSA-N
InChI=1S/C26H30N6O3/c1-26(2,27)25(35)31-22(11-16-13-28-20-9-5-3-7-18(16)20)24(34)32-23(30-15-33)12-17-14-29-21-10-6-4-8-19(17)21/h3-10,13-15,22-23,28-29H,11-12,27H2,1-2H3,(H,30,33)(H,31,35)(H,32,34)/t22-,23-/m1/s1
Molecular Formula | C26H30N6O3 |
Molecular Weight | 474.5548 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:21:23 UTC 2023
by
admin
on
Fri Dec 15 17:21:23 UTC 2023
|
Record UNII |
8680B21W73
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
V04CD06
Created by
admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
|
||
|
NCI_THESAURUS |
C76358
Created by
admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
|
||
|
NDF-RT |
N0000193785
Created by
admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9804938
Created by
admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
|
PRIMARY | |||
|
100000175809
Created by
admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
|
PRIMARY | |||
|
8680B21W73
Created by
admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
|
PRIMARY | |||
|
C95123
Created by
admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
|
PRIMARY | |||
|
1999420
Created by
admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
|
PRIMARY | |||
|
8680B21W73
Created by
admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
|
PRIMARY | |||
|
DB13074
Created by
admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
|
PRIMARY | |||
|
MACIMORELIN
Created by
admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
|
PRIMARY | |||
|
AB-25
Created by
admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
|
PRIMARY | |||
|
381231-18-1
Created by
admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
|
PRIMARY | |||
|
5271
Created by
admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
|
PRIMARY | |||
|
DTXSID601045766
Created by
admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
|
PRIMARY | |||
|
m12057
Created by
admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
|
PRIMARY | |||
|
9073
Created by
admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
|
PRIMARY | |||
|
CHEMBL278623
Created by
admin on Fri Dec 15 17:21:23 UTC 2023 , Edited by admin on Fri Dec 15 17:21:23 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
TARGET -> AGONIST |
test for adult GH deficiency:
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||
Tmax | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||